A longitudinal comparison of two neurocognitive test batteries in patients with schizophrenia and healthy volunteers: Time effects on neuropsychological performance and their relation to functional outcome.

Cognitive impairment is a major unmet need in the treatment of schizophrenia. Over the last decade, the MATRICS Consensus Cognitive Battery (MCCB) has been used to assess the effects of novel treatments for cognitive impairment in schizophrenia. However, other cognitive-neuroscience-based cognitive...

Full description

Bibliographic Details
Published in:Schizophrenia Research Vol. 216; pp. 347 - 357
Main Authors: Rodriguez-Toscano, Elisa, López, Gonzalo, Mayoral, Maria, Lewis, Shon, Lees, Jane, Drake, Richard, Arango, Celso, Rapado-Castro, Marta
Format: research Journal Article
Published: Elsevier B.V. Feb2020
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=143233113&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 143233113
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09209964
        3PT
      jtl: Schizophrenia Research
      issn: 09209964
      maglogo: N
    pubinfo:
      dt: Feb2020
      vid: 216
      pid: 1004
      pub: Elsevier B.V.
    artinfo:
      ui:
        143233113
        143233113
        NLM31813804
        143233113
        10.1016/j.schres.2019.11.018
        NLM31813804
        143233113
      ppf: 347
      ppct: 10
      formats:
      tig:
        atl: A longitudinal comparison of two neurocognitive test batteries in patients with schizophrenia and healthy volunteers: Time effects on neuropsychological performance and their relation to functional outcome.
      aug:
        au:
          Rodriguez-Toscano, Elisa
          López, Gonzalo
          Mayoral, Maria
          Lewis, Shon
          Lees, Jane
          Drake, Richard
          Arango, Celso
          Rapado-Castro, Marta
        affil: Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM, CIBERSAM, Madrid, Spain
      sug:
        subj:
          Psychotic Disorders Complications
          Schizophrenia Complications
          Human
          Psychology
          Cognition
          Neuropsychological Tests
          Comparative Studies
          Multicenter Studies
          Evaluation Research
          Validation Studies
      ab: Cognitive impairment is a major unmet need in the treatment of schizophrenia. Over the last decade, the MATRICS Consensus Cognitive Battery (MCCB) has been used to assess the effects of novel treatments for cognitive impairment in schizophrenia. However, other cognitive-neuroscience-based cognitive batteries, such as the Cambridge Neuropsychological Test Automated Battery (CANTAB) have been suggested as an alternative to the MCCB. Although both batteries purport to assess cognitive function in psychosis, no previous study has attempted to examine their validity longitudinally and the potential overlap between the two batteries over time. The aim of the current study was to assess the relationship between the MCCB and the CANTAB in the longitudinal assessment of cognitive impairment in schizophrenia. A sample of 39 stable schizophrenia outpatients and 18 controls completed the MCCB and the CANTAB battery at baseline, and at 2, 4 and 8-weeks follow-up. Correlation analyses and a mixed-model repeated measures approach were used. We found no significant effect of time in the MCCB. In contrast, for the CANTAB a significant effect of time consistent with practice effects for the attention domain in the control group and for the visual learning, reasoning and problem-solving, and social cognition domains in patients, with subjects performing better at follow-up. In particular, a significant time ∗ battery interaction was found for those cognitive domains. These findings suggest there are specific differences across cognitive tests to assess cognitive impairments in schizophrenia and that measures derived from the CANTAB appear to be more prone to practice effects in these patients.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N